 |
AC |  |
| ISIN | FR0000120404 |
| Security | AC |
| Exchange | ICE Europe |
| Type | Future |
Futures
| Exp. date | Last | Open Interest | |
|---|---|---|---|
| 4/20 | |||
| 5/20 | |||
| 6/20 | |||
| 7/20 | |||
| 8/20 | |||
| 9/20 | |||
| 10/20 | |||
| 11/20 | |||
| 12/20 | |||
| 1/21 | |||
| 2/21 | |||
| 3/21 | |||
| 4/21 | |||
| 5/21 | |||
| 6/21 | |||
| 7/21 | |||
| 8/21 | |||
| 9/21 | |||
| 10/21 | |||
| 11/21 | |||
| 12/21 | |||
| 1/22 | |||
| 2/22 | |||
| 3/22 | |||
| 4/22 | |||
| 5/22 | |||
| 6/22 | |||
| 7/22 | |||
| 8/22 | |||
| 9/22 | |||
| 10/22 | |||
| 11/22 | |||
| 12/22 | |||
| 1/23 | |||
| 2/23 | |||
| 3/23 | |||
| 4/23 | |||
| 5/23 | |||
| 6/23 | |||
| 7/23 | |||
| 8/23 | |||
| 9/23 | |||
| 10/23 | |||
| 11/23 | |||
| 12/23 | |||
| 1/24 | |||
| 2/24 | |||
| 3/24 | |||
| 4/24 | |||
| 5/24 | |||
| 6/24 | |||
| 7/24 | |||
| 8/24 | |||
| 9/24 | |||
| 10/24 | |||
| 11/24 | |||
| 12/24 | |||
| 1/25 | |||
| 2/25 | |||
| 3/25 |
News
- HARTFORD CYBERSECURITY EXECUTIVES TO GATHER IN VIRTUAL SUMMIT, AMID CONTINUING COVID-19 CONCERNS
04/07/2020 / 16:12 - GlobeNewswire - AC Immune Presents the Latest Preclinical Data on Novel Drug Targets for Neurodegenerative Diseases
04/02/2020 / 13:00 - GlobeNewswire - AC Immune Reports Full-Year 2019 Financial Results and Provides 2020 R&D Outlook
03/30/2020 / 13:00 - GlobeNewswire - Europe finishes lower on coronavirus concerns
03/27/2020 / 17:30 - TeleTrader - AC Immune Receives Second Milestone and New Milestone to Increase the Potential Deal Value of Lilly Morphomer™ Tau Partnership
03/23/2020 / 12:00 - GlobeNewswire
Real-time